About Henry Rath
Henry Rath is a chief business officer at Claris Biotherapeutics.
Henry Rath first appears on SEC filings in 2024.
Experience
This experience comes from Henry Rath's profile and from SEC filings. For roles taken from filings, the years are when the filings name Henry Rath in the role, so the role may have started earlier or lasted longer.
Claris Biotherapeutics, Inc. Current
Chief Business Officer
2023 – Present · Half Moon Bay, CA
Develops eye treatments for people with sight-threatening corneal diseases.
SI
Surface Oncology Inc.
Chief Business Officer
2021 – 2023
TT
TScan Therapeutics
Chief Business Officer
2019 – 2021
ST
Seres Therapeutics
Senior Vice President Corporate Development
2015 – 2019
CI
Catabasis Pharmaceuticals, Inc.
Vice President, Business Development
2012 – 2014
AM
Amgen
Executive Director, Corporate Development
2003 – 2012
BB
Baxter BioScience
Senior Manager
2002 – 2003
LC
L.E.K. Consulting
Senior Consultant
1999 – 2002
CO
CIBC Oppenhimer
Financial Analyst, Corporate Finance
1995 – 1997
AI
APM Incoorporated
Junior Associate
1993 – 1995
Key Colleagues at Startups
The people Henry Rath works with at each company, as listed on that company's latest Form D.
Claris Biotherapeutics, Inc. · Form D/A, Aug 12, 2026
Brian Baum
Chief Commercial Officer
MF
Meredith Fisher
Director
RD
Reza Dana
Director
Stephen Brady
President and Chief Executive Officer, director
KH
Kenneth Harrison
Director
MH
Matt Hobson
Director
MD
Michael Dybbs
Director
MR
Maha Radhakrishnan
Director
Susan Orr
Chief Medical Officer
Clarke Atwell
Co-Founder and Chief Operating Officer
MG
Marc de Garidel
Director